Vanguard Capital Wealth Advisors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
CS
LP
FCM
Vanguard Capital Wealth Advisors's AGN Position: Q3 2019 in Review
Vanguard Capital Wealth Advisors sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 1,266 shares — an estimated $211K sold.
Vanguard Capital Wealth Advisors first reported a position in AGN in Q1 2018 and held it in 4 quarters. The position peaked at $684K in Q2 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.
- Vanguard Capital Wealth Advisors reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
- Vanguard Capital Wealth Advisors sold 1,266 Allergan plc shares in Q3 2019, an estimated $211K.
- Vanguard Capital Wealth Advisors first reported a position in Allergan plc in Q1 2018 and held it in 4 quarters.
- Vanguard Capital Wealth Advisors's Allergan plc position peaked at $684K in Q2 2018.
- 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.
Based on Vanguard Capital Wealth Advisors's 13F filing for Q3 2019, filed 18 Oct 2019.